Rebuilding Manroland Sheetfed in India

Interview — Neeraj Dargan

The Manroland in-line foiler installed at Borkar Packaging

Recognition for MiraCradle-Neonate CoolerPluss Polymers’ medical technology at IIGP 2015Pluss Polymers, one of the leaders in research, development and manufacturing of specialty polymers and Phase Change Materials (PCMs), has been recognized by the Federation of Indian Chambers of Commerce and Industry (FICCI) for its cutting-edge medical technology – MiraCradle-Neonate Cooler. It has secured the fourth rank among top 30 innovations at the India Innovation Growth Programme (IIGP) 2015.Pluss Polymers has been recognized by FICCI for its cutting-edge medical technology – MiraCradle-Neonate Cooler. The company has secured the fourth rank among top 30 innovations at the India Innovation Growth Programme 2015.Samit Jain, managing director, Pluss Polymers, commented on the occasion, “This recognition inspires us to thrust ourselves further and make this technology available in every nook and corner of the country and reduce neonatal deaths. It motivates us to strive towards bringing in revolutionary technologies in various fields and put Pluss on the global innovation map. The top three technologies that secured the first, second and third positions at the IIGP 2015 are XrayTo3D software to make 3D images out of X-rays, Tabplan3D – a preventive technique to help patients manage kidney disease and Dance Aid for Deaf respectively.

During the first phase of the programme, a project team comprising of subject matter experts from FICCI selected 100 innovative technologies out of over 1,300 entries in a wide range of sectors such as aeronautics, agriculture, biotechnology, chemistry, communications, computing, defence, electronics, environment, healthcare, information technology, manufacturing, materials, life sciences, nanotechnology, petrochemicals, semi-conductors and transportation.

The IIGP is a joint initiative of the Department of Science and Technology, Government of India, Lockheed Martin Corporation; Indo-US Science and Technology Forum, FICCI; Stanford Graduate School of Business and the IC2 Institute at the University of Texas. The aim of this programme is to accelerate innovative Indian technologies into the global markets.

MiraCradle is an affordable treatment for neonatal asphyxia and will help India and the world get one step closer to the MDG 2015 goal. The product has been recognized in the past at the Kirloskar Technologies Awards in Chandigarh for Excellence and Innovation in Medical Devices and ‘Best Innovation & Research in Health Care’ at the Indo-Global Healthcare Summit & Expo 2014.